Personalized treatment approach for HER2-positive metastatic breast cancer
Breast cancer (BC) is a leading global concern for women, with 30% being HER2-positive
cases linked to poorer outcomes. Targeted therapies like trastuzumab deruxtecan (T-DXd) …
cases linked to poorer outcomes. Targeted therapies like trastuzumab deruxtecan (T-DXd) …
[HTML][HTML] αvβ3 integrin and folate-targeted pH-sensitive liposomes with dual ligand modification for metastatic breast cancer treatment
The advent of pH-sensitive liposomes (pHLips) has opened new opportunities for the
improved and targeted delivery of antitumor drugs as well as gene therapeutics. Comprising …
improved and targeted delivery of antitumor drugs as well as gene therapeutics. Comprising …
[HTML][HTML] Enhancing hair regeneration: Recent progress in tailoring nanostructured lipid carriers through surface modification strategies
Background and purpose Hair loss is a prevalent problem affecting millions of people
worldwide, necessitating innovative and efficient regrowth approaches. Nanostructured lipid …
worldwide, necessitating innovative and efficient regrowth approaches. Nanostructured lipid …
[HTML][HTML] HER-2 receptor and αvβ3 integrin dual-ligand surface-functionalized liposome for metastatic breast cancer therapy
Human epidermal growth factor receptor-2 (HER2)-positive breast cancer metastasis
remains the primary cause of mortality among women globally. Targeted therapies have …
remains the primary cause of mortality among women globally. Targeted therapies have …
Dual-ligand functionalized liposomes with iRGD/trastuzumab co-loaded with gefitinib and lycorine for enhanced metastatic breast cancer therapy
Personalized treatment strategies have greatly improved the efficacy of anticancer drugs.
Nanocarriers, especially liposomes, function as excellent platform for the delivery of both …
Nanocarriers, especially liposomes, function as excellent platform for the delivery of both …
NANOSTRUCTURE LIPID CARRIER TECHNOLOGY IN DRUG DELIVERY: ROUTE OF ADMINISTRATION, PREPARATION METHOD, CHARACTERIZATION, AND …
M Muliana, F Alatas - Medical Sains: Jurnal Ilmiah Kefarmasian, 2024 - ojs.ummada.ac.id
The new method, known as nanostructured lipid carrier (NLC) in drug delivery systems, has
the potential to increase therapeutic efficacy, stability, and bioavailability. This systematic …
the potential to increase therapeutic efficacy, stability, and bioavailability. This systematic …